Table 2 Baseline characteristics of WCD patients stratified by sex.

From: Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry

 

Female, n = 129

Male, n = 579

p-Value

Age, mean ± SD

61.58 ± 17.05

60.48 ± 14.04

0.441

WCD wear time (h/day), mean ± SD

21.53 ± 4.41

21.09 ± 4.29

0.282

WCD wear days, mean ± SD

56.60 ± 38.98

62.86 ± 44.36

0.140

WCD shocks, n (%)

5 (3.8)

14 (2.4)

0.082

Appropriate

5 (3.8)

11 (1.9)

0.259

Inappropriate

0 (0)

3 (0.5)

0.259

EF baseline, mean ± SD

30.17 ± 12.30

29.55 ± 11.14

0.549

EF follow-up, mean ± SD

38.18 ± 13.17

37.35 ± 12.17

0.486

EF improvement > 35%, n (%)

67 (51.9)

259 (44.7)

0.157

Device implantation, n (%)

41 (31.8)

203 (35.1)

0.330

Death during follow-up, n (%)

10 (7.7)

32 (5.5)

0.497

Compliance (> 20 h/day WCD use), n (%)

109 (84.5)

446 (77.0)

0.063

Back to article page